<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Colorectal Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Colorectal Dis</journal-id><journal-title-group><journal-title>International Journal of Colorectal Disease</journal-title></journal-title-group><issn pub-type="ppub">0179-1958</issn><issn pub-type="epub">1432-1262</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998692</article-id><article-id pub-id-type="pmc">PMC11861228</article-id>
<article-id pub-id-type="publisher-id">4845</article-id><article-id pub-id-type="doi">10.1007/s00384-025-04845-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Extended mesenteric resection reduces the rate of surgical recurrence in Crohn&#x02019;s disease: a systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vaghiri</surname><given-names>Sascha</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Alipouriani</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Knoefel</surname><given-names>Wolfram Trudo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kessler</surname><given-names>Hermann</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Prassas</surname><given-names>Dimitrios</given-names></name><address><email>Dimitrios.Prassas@med.uni-duesseldorf.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024z2rq82</institution-id><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Department of Surgery (A), </institution><institution>Heinrich-Heine-University, Medical Faculty and University Hospital Duesseldorf, </institution></institution-wrap>Moorenstr. 5, Bldg. 12.46, 40225 Duesseldorf, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03xjacd83</institution-id><institution-id institution-id-type="GRID">grid.239578.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0675 4725</institution-id><institution>Department for Colorectal Surgery, </institution><institution>Digestive Disease Institute, Cleveland Clinic, </institution></institution-wrap>9500 Euclid Avenue, Cleveland, OH 44195 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ybqnp73</institution-id><institution-id institution-id-type="GRID">grid.459415.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0558 5853</institution-id><institution>Department of Surgery, </institution><institution>Katholisches Klinikum Essen, Philippusstift, Teaching Hospital of Duisburg-Essen University, </institution></institution-wrap>Huelsmannstr, 17, 45355 Essen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>40</volume><issue>1</issue><elocation-id>51</elocation-id><history><date date-type="accepted"><day>18</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Mesenteric resection in Crohn&#x02019;s disease (CD) is still controversial and under discussion. We performed a meta-analysis to assess recurrence rates and operative-related morbidity based on the extent of mesenteric resection.</p></sec><sec><title>Methods</title><p id="Par2">A comprehensive literature research was conducted until November 2024 using PubMed (Medline), the Cochrane Central trials register, and Google Scholar databases. Studies before the biological era or with Kono-S anastomosis were excluded. Data from comparative studies with reported patient characteristics and outcome results of extended and limited mesenteric resections were extracted and subsequently entered into a pairwise meta-analysis model. Odds ratios (ORs) for dichotomous variables and standardized mean differences (SMDs) for continuous outcomes with 95% confidence intervals (CIs) were calculated. The risk of bias was rated according to ROBINS-I and Rob2 criteria, respectively.</p></sec><sec><title>Results</title><p id="Par3">Four non-randomized studies and one randomized trial with a total of 4358 patients (extended mesenteric resection: <italic>n</italic>&#x02009;=&#x02009;993 versus mesenteric preservation: <italic>n</italic>&#x02009;=&#x02009;3365) met eligibility criteria and were included. Extended mesenteric resection was significantly associated with reduced surgical recurrence rates compared to mesenteric preservation (OR&#x02009;=&#x02009;4.94; 95% CI [2.22&#x02013;10.97]; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0%). In terms of endoscopic recurrence, postoperative morbidity, and hospital stay, no significant differences between both groups were noted within the short follow-up period.</p></sec><sec><title>Conclusion</title><p id="Par4">Extended mesenteric resection demonstrated a lower surgical recurrence rate in Crohn&#x02019;s disease, while morbidity rates were comparable to the mesenteric sparing approach, whether extended mesenteric excision should be recommended requires further high-quality randomized trials with long-term follow-up data.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00384-025-04845-6.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Crohn&#x02019;s disease</kwd><kwd>Mesenteric resection</kwd><kwd>Recurrence rate</kwd><kwd>Complications</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsklinikum D&#x000fc;sseldorf. Anstalt &#x000f6;ffentlichen Rechts (8911)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Over the course of the last three decades, major breakthroughs have been made, unlocking novel therapeutic strategies for patients with Crohn&#x02019;s disease (CD). Despite of this, the majority will have to undergo one or more surgeries over their lifetime [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. As a result, this raises the question of the appropriateness of contemporary surgical methods which, more or less, have not evolved at the same pace. Two distinct stages of the surgical approach can be individually investigated and modified in order to pursue a better outcome, with the first one being the resectional and the second one the reconstructive stage. With regard to the latter, the introduction of the Kono-S anastomotic technique offers a potential option to reduce recurrence rates through the exclusion of the mesentery from the anastomosis and thus the prevention of anastomotic distortion [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The resectional stage has traditionally been based on the axiomatic approach of &#x0201c;as much as necessary &#x02013; as little as possible&#x0201d; referring more to the extent of intestinal length excision rather than the mesenteric radicality. The aspect of the excisional extent of the intestinal mesentery is not new. Based on reports that demonstrate the mesentery of the inflamed bowel as a discrete functional entity that has been associated with disease activity [<xref ref-type="bibr" rid="CR5">5</xref>], this organ has been targeted as its regulator [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par6">With the present work, we sought to meta-analyze all contemporary existing studies comparing limited to extended mesenteric excision of the bowel with regard to its efficiency and safety in patients with CD requiring surgical resection.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par7">This meta-analysis was conducted in accordance with the current PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and the latest version of the Cochrane Handbook for Systematic Reviews of Interventions, to ensure transparency and adequate study evidence [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p><sec id="Sec3"><title>Literature search</title><p id="Par8">Two authors (S.V. and A.A.) independently performed a comprehensive research for relevant literature in the PubMed (Medline), the Cochrane Central trials register, and Google Scholar databases until November 9, 2024, through screening of article titles and abstracts. No language restriction was applied. The following medical subject headings were combined with the Boolean operators AND or OR: [(mesenter* resection) AND Crohn&#x02019;s]. After full-text review, the reference lists of all selected and eligible articles were comprehensively checked for further potentially relevant citations. Disagreements were resolved by discussion and consensus or consultation of a third author (D.P.) if necessary.</p></sec><sec id="Sec4"><title>Inclusion and exclusion criteria</title><p id="Par9">All comparative studies such as randomized controlled trials (RCTs), and prospective or retrospective cohort studies reporting clinical outcomes of extended mesenteric resection as the intervention of interest (i.e. mesofascial separation and vascular mesenteric pedicle division at various levels) versus mesenteric preservation (mesenteric resection in bowel proximity [<xref ref-type="bibr" rid="CR10">10</xref>], comparator) during segmental bowel resection for Crohn&#x02019;s disease were included. The exclusion criteria were as follows: case/technical reports, editorials or narrative reviews, non-peer-reviewed articles, studies from the pre-biological era, studies comparing Kono-S anastomosis with conventional techniques, and studies that did not report specific outcomes of interest. For data integrity, the reported outcomes of interest in each included study should enable the calculation of odds ratios (ORs) with 95% confidence intervals (CIs). Only studies with adult participants were considered. Discrepancies in study selection were resolved either by consensus or by consultation with an independent third author (D.P.).</p></sec><sec id="Sec5"><title>Data extraction and outcomes of interest</title><p id="Par10">Two authors (S.V. and A.A.) independently collected all available and relevant data from studies meeting the inclusion criteria. The extracted data contain the following information: (a) study characteristics (authors, year and country of publication, enrollment period, study design and protocol, number of included patients), (b) patients baseline demographics, comorbidities, disease characteristics and medication, (c) surgical technique and intraoperative details, and (d) postoperative short- and long-term outcomes. If the authors were unable to achieve consistent results during data extraction, an independent third reviewer (D.P.) was consulted for advice. The primary endpoint was the rate of surgical recurrence (defined as the need of reoperation for recurrent CD). The secondary outcomes included endoscopic recurrence (defined as Rutgeerts score from i2 to i4 [<xref ref-type="bibr" rid="CR11">11</xref>], or modified Rutgeerts&#x02019; score of i2b or higher [<xref ref-type="bibr" rid="CR12">12</xref>] within 6&#x02013;12&#x000a0;months after index surgery), duration of surgery, protective ostomy, anastomotic leak, transfusion, surgical site infection (SSI), overall morbidity, major complications (according to Clavien-Dino and ACS-NSQIP, respectively [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]), mortality, and length of hospital stay.</p></sec><sec id="Sec6"><title>Quality and certainty assessment</title><p id="Par11">The risk of bias for the included non-randomized studies was assessed using the ROBINS-I criteria as recommend in the Cochrane Handbook for Systematic Reviews of Interventions [<xref ref-type="bibr" rid="CR15">15</xref>]. This tool categorizes the risk of bias in non-randomized studies from low to critical based on seven potential bias domains. In parallel, the risk of bias of in one randomized study was evaluated using the RoB 2 criteria, which categorizes randomized trials into low to high risk of bias based on signaling questions derived from five potential bias domains [<xref ref-type="bibr" rid="CR16">16</xref>]. The revised AMSTAR 2 instrument was used to critically appraise this meta-analysis [<xref ref-type="bibr" rid="CR17">17</xref>]. The level of evidence for the significant outcomes was classified into four categories (high, moderate, low, and very low) according to GRADE (The Grading of Recommendations, Assessment, Development, and Evaluation) [<xref ref-type="bibr" rid="CR18">18</xref>]. Study quality and certainty judgement was performed independently by two authors (S.V and A.A.). Disagreements during this step were discussed and resolved by consensus or reassessment by a third author (D.P.).</p></sec><sec id="Sec7"><title>Statistical analyses</title><p id="Par12">Data of interest was analyzed with pairwise meta-analyses. For each primary and secondary outcome, summary treatment effect estimates with 95% confidence intervals (CIs) were calculated. For dichotomous endpoints, the odds ratio (OR) was chosen as the effect measure. Standardized mean differences (SMD) were calculated to analyze continuous outcomes. For continuous variables, the available data on medians and IQRs (interquartile range) have been converted into means and standard deviations applying the methods proposed by Luo et al. and Wan et al. [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Using the Cochrane <italic>Q</italic> test (chi-squared test; chi<sup>2</sup>) and the measurement of inconsistency (<italic>I</italic><sup>2</sup>), the degree of heterogeneity among the included studies was interpreted as follows: 0&#x02013;40% low heterogeneity and may not be important, 30&#x02013;60% moderate heterogeneity, 50&#x02013;90% substantial heterogeneity,&#x02009;&#x0003e;&#x02009;75% considerable heterogeneity [<xref ref-type="bibr" rid="CR8">8</xref>]. When heterogeneity was low or moderate (<italic>I</italic><sup>2</sup>&#x02009;&#x0003c;&#x02009;50%), summary estimates were calculated using a fixed-effects method. Where appropriate, subgroup analysis was conducted to ensure the robustness of the overall heterogeneity in the results. Leave-one-out analysis investigated the effect of each study on the pooled outcomes. Statistical significance was defined as <italic>p</italic> values&#x02009;&#x0003c;&#x02009;0.05 of pooled data. Statistical analysis was performed using RevMan software (version 5.3; Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Study and patient characteristics</title><p id="Par13">The initial literature research resulted in 19,166 studies for inclusion. After removing duplicates and non-contributory studies, 28 full-text manuscripts were screened, 23 of which were excluded taking into account the defined inclusion and exclusion criteria. Finally, five eligible studies involving 4550 patients remained that were subsequently included in the qualitative and quantitative meta-analysis [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> PRISMA Flowchart). In four non-randomized studies [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>] and one randomized trial [<xref ref-type="bibr" rid="CR25">25</xref>], a total of 4358 patients were analyzed (extended mesenteric resection: <italic>n</italic>&#x02009;=&#x02009;993 versus mesenteric preservation: <italic>n</italic>&#x02009;=&#x02009;3365). The male to female ratio was 2072:2286. The study enrollment period was from January 2004 to April 2023. Three studies originated from European countries [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], while one study was conducted in Canada [<xref ref-type="bibr" rid="CR24">24</xref>] and one in China [<xref ref-type="bibr" rid="CR22">22</xref>], respectively. The study of van der Does de Willeboise et al. [<xref ref-type="bibr" rid="CR25">25</xref>] was the only included multicenter RCT from the Netherlands with 133 patients. Abdulkarim et al. [<xref ref-type="bibr" rid="CR24">24</xref>] performed their study as a retrospective ACS database query including 3709 patients. Two studies were conducted as single-center studies [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] and one as a bi-center study [<xref ref-type="bibr" rid="CR23">23</xref>]. Patients exclusively undergoing ileocolic resection were included in three studies accounting for 12% of all performed procedures [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In contrast, two studies included patients with a various extent and location of colectomy (right colectomy 60.6%, transverse colectomy 0.2%, left colectomy 0.8%, total colectomy 0.5%, proctectomy 0.1%, and other non-defined segmental resections 25.9%) [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The application of biologicals at index surgery was mentioned in four studies with a total of 136 patients which corresponds to 21% of all patients in these studies [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Noteworthy, in two studies, follow-up ranged from 30&#x000a0;days to 6&#x000a0;months [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], in contrast to long-term outcome data provided in three other studies [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. A full and detailed study and patient summary is presented in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>PRISMA flowchart of study identification and selection</p></caption><graphic xlink:href="384_2025_4845_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Study characteristics and protocols</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Author</th><th align="left">Year</th><th align="left">Origin</th><th align="left">Recruitment period</th><th align="left">Study design</th><th align="left">Total sample size</th><th align="left">Inclusion criteria</th><th align="left">Type of procedure (groups)</th><th align="left">Type of access/surgeons involved</th><th align="left">Follow-up period (months) mean/SD</th><th align="left">Endpoint(s)</th></tr></thead><tbody><tr><td align="left">Coffey et al. [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">2018</td><td align="left">Ireland</td><td align="left">Jan 2004&#x02013;Apr 2010</td><td align="left">Single center, retrospective</td><td align="left">64</td><td align="left">Ileocolic resection for a Crohn&#x02019;s related ileocolic disease</td><td align="left"><p>Group A: conventional ileocolic resection</p><p>Group B: ileocolic resection with mesenteric excision</p></td><td align="left">Open and MIS/multiple</td><td align="left"><p>Group A: 69.9&#x02009;&#x000b1;&#x02009;48.47</p><p>Group B: 51.7&#x02009;&#x000b1;&#x02009;20.98</p></td><td align="left">Surgical recurrence</td></tr><tr><td align="left">Zhu et al. [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">2021</td><td align="left">China</td><td align="left">Jan 2000&#x02013;Dec 2018</td><td align="left">Single-center, prospective</td><td align="left">126</td><td align="left">Crohn&#x02019;s colitis with colorectal resection</td><td align="left"><p>LME: mesentery sparing colorectal resection</p><p>EME: mesentery mobilization and division 1-cm distant from the origin of the major arterial trunks</p></td><td align="left">NA</td><td align="left"><p>LME: 45.12 6&#x02009;&#x000b1;&#x02009;25.45</p><p>EME: 47.50&#x02009;&#x000b1;&#x02009;623.67</p></td><td align="left">Early postoperative short-term outcome and surgical recurrence</td></tr><tr><td align="left">Mineccia et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td align="left">2022</td><td align="left">Italy</td><td align="left">Jan 2009&#x02013;Dec 2019</td><td align="left">Bi-center, retrospective (Remedy study)</td><td align="left">326</td><td align="left">Crohn&#x02019;s disease localized to the terminal ileum</td><td align="left"><p>Group A: mesentery resection</p><p>Group B: mesentery preservation</p></td><td align="left">Open and MIS/multiple</td><td align="left">Median 4.7&#x02009;&#x000b1;&#x02009;3 (years)</td><td align="left">90-day complications, endoscopic FU, long-term surgical recurrence</td></tr><tr><td align="left">Abdulkarim et al. [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">2023</td><td align="left">Canada</td><td align="left">2014&#x02013;2019</td><td align="left">ACS-NSQIP database, retrospective</td><td align="left">3709</td><td align="left">Patients with CD undergoing segmental colectomy</td><td align="left"><p>Extended ME: lymph node harvest&#x02009;&#x02265;&#x02009;12</p><p>Limited ME:&#x02009;&#x0003c;&#x02009;12 lymph node</p></td><td align="left">Open and MIS/multiple</td><td align="left">30&#x000a0;days</td><td align="left">30-day NSQIP major morbidity, abdominal complications, perioperative bleeding</td></tr><tr><td align="left">van der Does de Willebois et al. [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">2024</td><td align="left">Netherlands</td><td align="left">Feb 2020&#x02013;Apr 2023</td><td align="left">Multicenter, RCT (SPICY trial -NCT 04538638)</td><td align="left">139</td><td align="left">Aged&#x02009;&#x02265;&#x02009;16 and Crohn&#x02019;s disease (L1 or L3 disease)</td><td align="left">Extended mesenteric resection (intervention) or conventional mesenteric sparing resection (control)</td><td align="left">MIS/multiple</td><td align="left">6&#x000a0;months</td><td align="left">Endoscopic recurrence 6&#x000a0;months after surgery</td></tr></tbody></table><table-wrap-foot><p><italic>CD</italic>, Crohn&#x02019;s disease; <italic>FU</italic>, follow-up; <italic>EME</italic>, extended mesenteric excision; <italic>LME</italic>, limited mesenteric excision; <italic>MIS</italic>, minimally invasive surgery; <italic>NA</italic>, not available; <italic>NSQIP</italic>, National Surgical Quality Improvement Program; <italic>RCT</italic>, randomized controlled trial; <italic>SD</italic>, standard deviation</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Patient-and disease characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Author</th><th align="left" rowspan="2">Groups</th><th align="left" rowspan="2">No. of patients</th><th align="left" rowspan="2">Age at surgery (years) mean/SD</th><th align="left" rowspan="2">Gender (M/F)</th><th align="left" rowspan="2">Disease duration (months) mean /SD</th><th align="left" rowspan="2">Biologicals at index surgery</th><th align="left" rowspan="2">Smoking</th><th align="left" colspan="4">Disease classification</th><th align="left" rowspan="2">Site of surgery</th></tr><tr><th align="left">Age</th><th align="left" colspan="2">Location</th><th align="left">Phenotype</th></tr></thead><tbody><tr><td align="left">Coffey et al. [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">LME</td><td align="left">30</td><td align="left">37.7&#x02009;&#x000b1;&#x02009;13.67</td><td align="left">14/16</td><td align="left">75.0&#x02009;&#x000b1;&#x02009;117.42</td><td align="left">5</td><td align="left">20</td><td align="left" colspan="2"><p>A1&#x02009;&#x0003c;&#x02009;40 23*</p><p>A2&#x02009;&#x02265;&#x02009;40 6</p></td><td align="left"><p>L1 23</p><p>L2 2</p><p>L3 4</p><p>L4 0</p></td><td align="left"><p>B1 16</p><p>B2 6</p><p>B3 8</p></td><td align="left">Ileocolic resection 30</td></tr><tr><td align="left"/><td align="left">EME</td><td align="left">34</td><td align="left">35.9&#x02009;&#x000b1;&#x02009;11.87</td><td align="left">14/20</td><td align="left">70.7&#x02009;&#x000b1;&#x02009;78.83</td><td align="left">15</td><td align="left">20</td><td align="left" colspan="2"><p>A1&#x02009;&#x0003c;&#x02009;40 26</p><p>A2&#x02009;&#x02265;&#x02009;40 6</p></td><td align="left"><p>L1 26</p><p>L2 0</p><p>L3 6</p><p>L4 2</p></td><td align="left"><p>B1 8</p><p>B2 14</p><p>B3 12</p></td><td align="left">Ileocolic resection 34</td></tr><tr><td align="left">Zhu et al. [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">LME</td><td align="left">60</td><td align="left">31.15&#x02009;&#x000b1;&#x02009;10.36</td><td align="left">47/13</td><td align="left">51.19&#x02009;&#x000b1;&#x02009;49.36</td><td align="left">4</td><td align="left">9</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 7&#x02020;</p><p>A2 17&#x02013;40 44</p><p>A3&#x02009;&#x0003e;&#x02009;40 12</p></td><td align="left"><p>L1 0</p><p>L2 32</p><p>L3 28</p><p>L4 1</p></td><td align="left"><p>B1 0</p><p>B2 20</p><p>B3 40</p></td><td align="left"><p>Right colectomy 26</p><p>Transverse colectomy 4</p><p>Left colectomy 21</p><p>Proctectomy 2</p><p>Total colectomy 7</p></td></tr><tr><td align="left"/><td align="left">EME</td><td align="left">66</td><td align="left">30.42&#x02009;&#x000b1;&#x02009;10.15</td><td align="left">42/24</td><td align="left">61.61&#x02009;&#x000b1;&#x02009;52.19</td><td align="left">4</td><td align="left">5</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 4</p><p>A2 17&#x02013;40 50</p><p>A3&#x02009;&#x0003e;&#x02009;40 12</p></td><td align="left"><p>L1 0</p><p>L2 41</p><p>L3 25</p><p>L4 4</p></td><td align="left"><p>B1 3</p><p>B2 39</p><p>B3 24</p></td><td align="left"><p>Right colectomy 32</p><p>Transverse colectomy 3</p><p>Left colectomy 14 Proctectomy 1</p><p>Total colectomy 16</p></td></tr><tr><td align="left">Mineccia et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td align="left">LME</td><td align="left">122</td><td align="left">40.7&#x02009;&#x000b1;&#x02009;16</td><td align="left">70/52</td><td align="left">7.7&#x02009;&#x000b1;&#x02009;8.6 (years median)</td><td align="left">16</td><td align="left">35</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 15&#x02020;</p><p>A2 17&#x02013;40 68</p><p>A3&#x02009;&#x0003e;&#x02009;40 39</p></td><td align="left">NA</td><td align="left"><p>B1 0</p><p>B2 40</p><p>B3 82</p></td><td align="left">Ileocolic resection 122</td></tr><tr><td align="left"/><td align="left">EME</td><td align="left">204</td><td align="left">40.5&#x02009;&#x000b1;&#x02009;14.7</td><td align="left">121/83</td><td align="left">7.5&#x02009;&#x000b1;&#x02009;8.3 (years median)</td><td align="left">32</td><td align="left">75</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 12</p><p>A2 17&#x02013;40 140</p><p>A3&#x02009;&#x0003e;&#x02009;40 52</p></td><td align="left">NA</td><td align="left"><p>B1 0</p><p>B2 67</p><p>B3 137</p></td><td align="left">Ileocolic resection 204</td></tr><tr><td align="left">Abdulkarim et al. [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">LME</td><td align="left">3087</td><td align="left">42.3&#x02009;&#x000b1;&#x02009;16.76</td><td align="left">1408/1679</td><td align="left">NA</td><td align="left">NA</td><td align="left">697</td><td align="left" colspan="2">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left"><p>Right colectomy 2165</p><p>Other segmental colectomy 922</p></td></tr><tr><td align="left"/><td align="left">EME</td><td align="left">622</td><td align="left">41.0&#x02009;&#x000b1;&#x02009;15.78</td><td align="left">299/323</td><td align="left">NA</td><td align="left">NA</td><td align="left">123</td><td align="left" colspan="2">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left"><p>Right colectomy 416</p><p>Other segmental colectomy 206</p></td></tr><tr><td align="left">van der Does de Willeboise et al. [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">LME</td><td align="left">66</td><td align="left">36.29&#x02009;&#x000b1;&#x02009;18.18</td><td align="left">28/38</td><td align="left">59.47&#x02009;&#x000b1;&#x02009;85.64</td><td align="left">25</td><td align="left">25</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 8&#x02020;</p><p>A2 17&#x02013;40 40</p><p>A3&#x02009;&#x0003e;&#x02009;40 18</p></td><td align="left"><p>L1 40</p><p>L3 26</p></td><td align="left"><p>B1 15</p><p>B2 29</p><p>B3 22</p></td><td align="left">Ileocolic resection 66</td></tr><tr><td align="left"/><td align="left">EME</td><td align="left">67</td><td align="left">40.58&#x02009;&#x000b1;&#x02009;23.48</td><td align="left">29/38</td><td align="left">58.99&#x02009;&#x000b1;&#x02009;61.36</td><td align="left">35</td><td align="left">30</td><td align="left" colspan="2"><p>A1&#x02009;&#x02264;&#x02009;16 4</p><p>A2 17&#x02013;40 38</p><p>A3&#x02009;&#x0003e;&#x02009;40 25</p></td><td align="left"><p>L1 44</p><p>L3 23</p></td><td align="left"><p>B1 22</p><p>B2 28</p><p>B3 17</p></td><td align="left">Ileocolic resection 67</td></tr></tbody></table><table-wrap-foot><p><italic>EME</italic>, extended mesenteric resection; <italic>LME</italic>, limited mesenteric resection; <italic>SD</italic>, standard deviation; <italic>NA</italic>, not available; <italic>ME</italic>, mesenteric excision</p><p><sup>*</sup>Vienna Classification</p><p><sup>&#x02020;</sup>Montreal Classification</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Study quality and risk of bias</title><p id="Par14">The overall risk of bias of the four included non- randomized studies was rated from serious to low based on the proposed seven bias domains in the ROBINS-I tool. The risk of bias in the domain of confounding was serious in one study [<xref ref-type="bibr" rid="CR21">21</xref>], moderate in one study [<xref ref-type="bibr" rid="CR24">24</xref>] and low in two studies [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The risk of bias in the domain selection of study participants was judged as moderate in all studies [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. The risk of bias arising from classification of interventions, deviations from intended interventions, and measurement of outcomes was rated low in all non-randomized studies [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. Two studies were observed to have moderate risk of bias in the domains missing outcomes and selection of reported results [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Furthermore, the only randomized study was analyzed as having some risk of bias concerns especially in the categories missing outcome data and selection of the reported results, respectively [<xref ref-type="bibr" rid="CR25">25</xref>]. The methodological quality of the pooled evidence in this meta-analysis was determined as &#x0201c;high&#x0201d; using the AMSTAR 2 quality assessment tool. The risk of bias evaluation is demonstrated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Risk of bias summary according to <bold>a</bold> ROBINS-I, <bold>b</bold> RoB2</p></caption><graphic xlink:href="384_2025_4845_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec11"><title>Primary outcome</title><sec id="Sec12"><title>Surgical recurrence</title><p id="Par15">Surgical recurrence as the primary outcome was reported in three studies with a total of 416 patients [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. Meta-analysis of the pooled data revealed a significantly lower rate of surgical recurrence associated with extended mesenteric resection compared to the control group (OR&#x02009;=&#x02009;4.94; 95%CI [2.22&#x02013;10.97]; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001). The rate of heterogeneity was notably low (<italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0%, chi<sup>2</sup> test: <italic>p</italic>&#x02009;=&#x02009;0.51) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The certainty of evidence was judged as high based on GRADE criteria (Table suppl. <xref rid="MOESM2" ref-type="media">1</xref>).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Forrest plot for primary outcome extended mesenteric resection versus control: surgical recurrence</p></caption><graphic xlink:href="384_2025_4845_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec13"><title>Secondary outcomes</title><p id="Par16">Non-significant differences between extended mesenteric resection and mesenteric preservation were observed for all secondary outcomes of interest, especially overall and severe postoperative morbidity was not increased with extended mesenteric resection. The results are presented in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>.
<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Non-significant secondary outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left" colspan="2">No. of included patients</th><th align="left"/><th align="left"/><th align="left" colspan="2">Heterogeneity level</th></tr><tr><th align="left">Outcomes</th><th align="left">No. of included studies</th><th align="left">Mesenteric preservation</th><th align="left">Mesenteric excision</th><th align="left">SMD/OR [95% CI]</th><th align="left"><italic>P</italic>-value</th><th align="left"><italic>I</italic><sup>2</sup> (%)</th><th align="left"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left">Endoscopic recurrence</td><td align="left">2 [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">187</td><td align="left">270</td><td align="left">1.07 [0.73&#x02013;1.56]</td><td char="." align="char">0.72</td><td align="left">0</td><td char="." align="char">0.89</td></tr><tr><td align="left">Surgery duration (min)</td><td align="left">3 [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">3274</td><td align="left">892</td><td align="left">&#x02009;&#x02212;&#x02009;0.04 [&#x02212;&#x02009;0.12&#x02013;0.03]</td><td char="." align="char">0.26</td><td align="left">0</td><td char="." align="char">0.48</td></tr><tr><td align="left">Protective ostomy</td><td align="left">2 [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">3147</td><td align="left">688</td><td align="left">1.10 [0.80&#x02013;1.52]</td><td char="." align="char">0.56</td><td align="left">0</td><td char="." align="char">0.44</td></tr><tr><td align="left">Anastomotic leak</td><td align="left">3 [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">2980</td><td align="left">721</td><td align="left">1.06 [0.35&#x02013;3.24]</td><td char="." align="char">0.91</td><td align="left">51</td><td char="." align="char">0.13</td></tr><tr><td align="left">Transfusion</td><td align="left">2 [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">3147</td><td align="left">688</td><td align="left">0.86 [0.63&#x02013;1.18]</td><td char="." align="char">0.36</td><td align="left">0</td><td char="." align="char">0.77</td></tr><tr><td align="left">Surgical site infection</td><td align="left">2 [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">3147</td><td align="left">688</td><td align="left">1.00 [0.77&#x02013;1.31]</td><td char="." align="char">0.99</td><td align="left">0</td><td char="." align="char">0.60</td></tr><tr><td align="left">Overall morbidity</td><td align="left">3 [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">3269</td><td align="left">892</td><td align="left">1.13 [0.94&#x02013;1.37]</td><td char="." align="char">0.21</td><td align="left">0</td><td char="." align="char">0.71</td></tr><tr><td align="left">Major morbidity</td><td align="left">3 [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">3274</td><td align="left">892</td><td align="left">1.01 [0.81&#x02013;1.26]</td><td char="." align="char">0.90</td><td align="left">0</td><td char="." align="char">0.48</td></tr><tr><td align="left">Mortality</td><td align="left">4 [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">3334</td><td align="left">958</td><td align="left">1.96 [0.27&#x02013;14.52]</td><td char="." align="char">0.51</td><td align="left">0</td><td char="." align="char">0.89</td></tr><tr><td align="left">Length of hospital stay (days)</td><td align="left">4 [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">3334</td><td align="left">958</td><td align="left">0.02 [&#x02212;&#x02009;0.06&#x02013;0.09]</td><td char="." align="char">0.69</td><td align="left">28</td><td char="." align="char">0.24</td></tr></tbody></table><table-wrap-foot><p><italic>CI</italic>, confidence interval; <italic>OR</italic>, odds ratio; <italic>SMD</italic>, standardized mean difference</p></table-wrap-foot></table-wrap></p></sec></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par17">Extended mesenteric excision is not a novel concept [<xref ref-type="bibr" rid="CR26">26</xref>], but is increasingly utilized, in conjunction with modern medical treatment regimens and alternative anastomotic approaches, as an efficient amendment to the classic tubular bowel resection. The mesentery-preserving strategy is based on the hypothesis that the biological profile of CD is mostly dependent on gut microbiome and the intestinal barrier. Coffey et al. [<xref ref-type="bibr" rid="CR27">27</xref>] revitalized the interest towards the mesentery as a distinct anatomic and pathophysiologic entity by underlining its role in metabolism and as mediator of immune response. Increasing evidence shows that structural abnormalities of the mesentery are closely linked to disease progression and recurrence, rendering it a key mediator of inflammatory activity due to interaction between adipocytes, neuropeptides and lymphatic and vascular endothelia, causing remodeling of the involved adipose tissue [<xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. Again, Coffey et al. [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR27">27</xref>] were the first to revive this concept and implement it into surgical practice by conducting the first contemporary comparative study of tubular versus extended resections for CD, with more studies following. Here, it should be highlighted that the specimen length was mentioned in only three included studies [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] and two authors provided data on the resection status [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In two studies [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], there was a clear trend towards a longer specimen length in the limited mesenteric approach, while in the study by van der Does de Willeboise et al. [<xref ref-type="bibr" rid="CR25">25</xref>] only the ileal specimen was longer in the mesenteric sparing group. On the other hand, in the study by Zhu et al. [<xref ref-type="bibr" rid="CR22">22</xref>], the CD affected resection margins did not differ significantly between the two groups with limited and extended resection, while van der Does de Willeboise et al. [<xref ref-type="bibr" rid="CR25">25</xref>] reported a higher inflammatory involvement of the distal colonic margin in the group with limited resection as opposed to extended mesenteric excision (18% versus 5%, <italic>p</italic>&#x02009;=&#x02009;0.023). Interestingly, recurrence rates do not appear to correlate with margin status and specimen length based on the data of the included studies. This in turn is a contrast to a recently published meta-analysis, demonstrating inflammatory margins to be associated with postoperative recurrence after ileocecal resection in CD [<xref ref-type="bibr" rid="CR32">32</xref>]. At this point, it must be noted that the term radical excision does not always imply the exact same operative technique. Zhu et al. [<xref ref-type="bibr" rid="CR22">22</xref>] and Mineccia et al. [<xref ref-type="bibr" rid="CR23">23</xref>] define it as full mesenteric mobilization with division in close proximity to the major arterial trunks, similar to oncologic colorectal resections, whereas Coffey et al. [<xref ref-type="bibr" rid="CR21">21</xref>] describe his technique as division of the mesentery as close to the mesenteric root as deemed safe. On the other hand, the mesenteric resections in the SPICY study [<xref ref-type="bibr" rid="CR25">25</xref>] were performed following the lower border of the ileocolic artery, preserving its vascular trunk. The lack of predefined mesenteric borders of the resection is most prominent in the study of Abdulkarim et al. [<xref ref-type="bibr" rid="CR24">24</xref>], in which lymph node harvest alone was used as a surrogate for radicality. This is the first meta-analysis of studies comparing the above-mentioned procedures. Upon extensive literature research, six comparative contemporary studies and one trial from 1989 [<xref ref-type="bibr" rid="CR26">26</xref>] were identified. In order to eliminate the potential heterogeneity generated by the synergistic effects of concomitant medications of different classes on treatment response, we opted for exclusion of trials published in the pre-biologic era [<xref ref-type="bibr" rid="CR33">33</xref>]. This exclusion criterion becomes more important when one considers that in Coffey&#x02019;s study, 44.1% of patients in the mesenteric excision group (recurrence rate 3%) had biologic therapy at index surgery compared to only 16.7% in the non-excision group which is further related to the different time periods of surgery in both groups [<xref ref-type="bibr" rid="CR34">34</xref>]. The Kono-S anastomosis has been shown to have a positive effect on reducing disease recurrence [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], so we excluded one study comparing the Kono-S, extended mesenteric resection and the combination of Kono-S and extensive mesenteric resection techniques to ensure homogeneity and comparability [<xref ref-type="bibr" rid="CR37">37</xref>]. Our meta-analysis demonstrated homogeneous results in support of extended mesenteric resection with regard to clinical recurrence requiring surgery (OR&#x02009;=&#x02009;4.94; 95% CI [2.22&#x02013;10.97]; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0%). Endoscopic recurrences were reported in just two of the included studies [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Despite the higher incidence in the non-excisional subgroup, this effect did not manage to reach statistical significance. One possible explanation of this finding would be the relatively short follow-up period of six months in the SPICY trial [<xref ref-type="bibr" rid="CR25">25</xref>]. This becomes clear when one considers the recurrence rates of up to 40% in patients with negative initial postoperative surveillance endoscopy, after a median follow-up period of 3.5&#x000a0;years [<xref ref-type="bibr" rid="CR38">38</xref>]. Furthermore, in light of our results regarding surgical recurrence, the fact that disease progression is linear suggests that endoscopic recurrence could be higher at longer surveillance. Long-time results of the SPICY trial are yet to be published [<xref ref-type="bibr" rid="CR39">39</xref>]. Another important clue is the different endoscopic scoring system in the two included studies in which endoscopic recurrence was investigated. While Mineccia et al. [<xref ref-type="bibr" rid="CR23">23</xref>] used the Rutgeerts score for endoscopic recurrence evaluation, in the study of van der Does de Willebois et al. [<xref ref-type="bibr" rid="CR25">25</xref>], endoscopic recurrence was judged by the modified Rutgeerts classification. An accurate diagnosis and classification of the endoscopic recurrence is of the utmost importance, as it determines the further disease course, the type of medical treatment, and the quality of life [<xref ref-type="bibr" rid="CR40">40</xref>]. In this context, a recent meta-analysis of 76 studies showed a wide variation in endoscopic recurrence (5&#x02013;93%) after surgical resection for CD, depending on the endoscopic scoring system used [<xref ref-type="bibr" rid="CR41">41</xref>]. Ultimately, the identification of high-risk individuals with regard to recurrence and CD-related morbidity is the fundamental aim of postoperative management. The guidelines published by the American Gastroenterological Association in 2017 have generally served as the guiding beacon for stratifying and accordingly treating patients at risk, and have recently been renewed by the new practice guideline published in 2024 [<xref ref-type="bibr" rid="CR42">42</xref>]. Studies included in the present meta-analysis demonstrate a rather inhomogeneous pattern with regard to the above matter, reflecting the need for a more standardized algorithmic approach of postoperative medical management. There was no statistically significant difference noted, concerning overall postoperative morbidity within the two study groups. Even after investigating various postoperative complications, still both approaches were found to deliver comparable results. Nevertheless, most of those secondary outcome assumptions derive from pooling of just two studies and should be interpreted cautiously. The presented finding could have a trend-setting impact on the current surgical practice in CD. The latest European Crohn&#x02019;s and Colitis Organization (ECCO) guidelines state that there is insufficient evidence supporting extended mesenteric excision in ileocecal CD [<xref ref-type="bibr" rid="CR43">43</xref>]. Recent studies have shown that postoperative disease recurrence is significantly lower depending on the type of anastomotic technique and the extent of resection margin involvement [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], indicating that surgical procedures for CD can be further improved and optimized [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p id="Par18">Our meta-analysis has some limitations. Firstly, the number of studies that could be included was relatively low. Surgical expertise of the operating surgeons was variable and thus a potential source of bias. The heterogeneity of the present meta-analysis with regard to inclusion of non-exclusively ileocecal resections and the use of different operative techniques may influence comparability of the presented results. Postoperative surveillance strategies, medical treatment regimens that change even within the same study period and follow-up time vary significantly. In addition, positive resection margins should be taken into consideration in future comparative trials as a significant confounding factor for disease recurrence, perhaps by excluding selected cases and/or matching between study arms as appropriate. Only one of the included studies was a randomized controlled trial [<xref ref-type="bibr" rid="CR25">25</xref>]. Long-time results of this trial, as well as preliminary results of other ongoing RCTs are yet to be published [<xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>].</p></sec><sec id="Sec15"><title>Conclusion</title><p id="Par19">Extended mesenteric resection was associated with a reduced incidence of postoperative surgical recurrence of Crohn&#x02019;s disease, without demonstrating any additional morbidity. Due to the lack of high-quality trials, non-standardized operative technique, varying postoperative endoscopic surveillance classification, and heterogeneity of postoperative medical treatment, the results should be interpreted with caution.</p></sec><sec id="Sec16" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="384_2025_4845_MOESM1_ESM.docx"><caption><p>Supplementary file1&#x000a0;- PRISMA checklist (DOCX 31.4 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="384_2025_4845_MOESM2_ESM.docx"><caption><p>Supplementary file2&#x000a0;-&#x000a0;The GRADE Certainty assessment for significant outcomes (DOCX 14.3 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>Study conception and design (D.P. and S.V.), Literature search and study selection (D.P., S.V., and A.A.), Acquisition and extraction of data (S.V. and A.A.), Analysis and interpretation of data (D.P. and S.V.), Statistical analysis (D.P.), Drafting of manuscript (S.V. and D.P.), Critical review and revision of manuscript (W.T.K. and H.K.). All the authors approved the final manuscript version.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval</title><p id="Par20">This article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, no ethical approval was required and obtained.</p></notes><notes id="FPar2"><title>Informed consent</title><p id="Par21">For this type of study informed consent was not required.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interest</title><p id="Par22">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>RT</given-names></name><name><surname>Maron</surname><given-names>DJ</given-names></name></person-group><article-title>Efficacy and complications of surgery for Crohn&#x02019;s disease</article-title><source>Gastroenterol Hepatol (N Y)</source><year>2010</year><volume>6</volume><fpage>587</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">21088749</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Lewis RT, Maron DJ (2010) Efficacy and complications of surgery for Crohn&#x02019;s disease. Gastroenterol Hepatol (N Y) 6:587&#x02013;596<pub-id pub-id-type="pmid">21088749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Chardavoyne</surname><given-names>R</given-names></name><name><surname>Flint</surname><given-names>GW</given-names></name><name><surname>Pollack</surname><given-names>S</given-names></name><name><surname>Wise</surname><given-names>L</given-names></name></person-group><article-title>Factors affecting recurrence following resection for Crohn&#x02019;s disease</article-title><source>Dis Colon Rectum</source><year>1986</year><volume>29</volume><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1007/BF02562601</pub-id><pub-id pub-id-type="pmid">3731965</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Chardavoyne R, Flint GW, Pollack S, Wise L (1986) Factors affecting recurrence following resection for Crohn&#x02019;s disease. Dis Colon Rectum 29:495&#x02013;502. 10.1007/BF02562601<pub-id pub-id-type="pmid">3731965</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Kono</surname><given-names>T</given-names></name><name><surname>Fichera</surname><given-names>A</given-names></name></person-group><article-title>Surgical treatment for Crohn&#x02019;s disease: a role of Kono-S anastomosis in the west</article-title><source>Clin Colon Rectal Surg</source><year>2020</year><volume>33</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1055/s-0040-1714236</pub-id><pub-id pub-id-type="pmid">33162837</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Kono T, Fichera A (2020) Surgical treatment for Crohn&#x02019;s disease: a role of Kono-S anastomosis in the west. Clin Colon Rectal Surg 33:335&#x02013;343. 10.1055/s-0040-1714236<pub-id pub-id-type="pmid">33162837</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Cathomas</surname><given-names>M</given-names></name><name><surname>Saad</surname><given-names>B</given-names></name><name><surname>Taha-Mehlitz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Safety and effectivity of Kono-S anastomosis in Crohn&#x02019;s patients: a systematic review and Meta-analysis</article-title><source>Langenbecks Arch Surg</source><year>2024</year><volume>409</volume><fpage>227</fpage><pub-id pub-id-type="doi">10.1007/s00423-024-03412-x</pub-id><pub-id pub-id-type="pmid">39037448</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Cathomas M, Saad B, Taha-Mehlitz S et al (2024) Safety and effectivity of Kono-S anastomosis in Crohn&#x02019;s patients: a systematic review and Meta-analysis. Langenbecks Arch Surg 409:227. 10.1007/s00423-024-03412-x<pub-id pub-id-type="pmid">39037448</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Desreumaux</surname><given-names>P</given-names></name><name><surname>Ernst</surname><given-names>O</given-names></name><name><surname>Geboes</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inflammatory alterations in mesenteric adipose tissue in Crohn&#x02019;s disease</article-title><source>Gastroenterology</source><year>1999</year><volume>117</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/s0016-5085(99)70552-4</pub-id><pub-id pub-id-type="pmid">10381912</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Desreumaux P, Ernst O, Geboes K et al (1999) Inflammatory alterations in mesenteric adipose tissue in Crohn&#x02019;s disease. Gastroenterology 117:73&#x02013;81. 10.1016/s0016-5085(99)70552-4<pub-id pub-id-type="pmid">10381912</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>JC</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>DP</given-names></name><name><surname>Kiernan</surname><given-names>MG</given-names></name><name><surname>Faul</surname><given-names>P</given-names></name></person-group><article-title>The mesentery in Crohn&#x02019;s disease: friend or foe?</article-title><source>Curr Opin Gastroenterol</source><year>2016</year><volume>32</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1097/MOG.0000000000000280</pub-id><pub-id pub-id-type="pmid">27115218</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Coffey JC, O&#x02019;Leary DP, Kiernan MG, Faul P (2016) The mesentery in Crohn&#x02019;s disease: friend or foe? Curr Opin Gastroenterol 32:267&#x02013;273. 10.1097/MOG.0000000000000280<pub-id pub-id-type="pmid">27115218</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>JC</given-names></name><name><surname>Byrnes</surname><given-names>KG</given-names></name><name><surname>Walsh</surname><given-names>DJ</given-names></name><name><surname>Cunningham</surname><given-names>RM</given-names></name></person-group><article-title>Update on the mesentery: structure, function, and role in disease</article-title><source>Lancet Gastroenterol Hepatol</source><year>2022</year><volume>7</volume><fpage>96</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(21)00179-5</pub-id><pub-id pub-id-type="pmid">34822760</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Coffey JC, Byrnes KG, Walsh DJ, Cunningham RM (2022) Update on the mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 7:96&#x02013;106. 10.1016/S2468-1253(21)00179-5<pub-id pub-id-type="pmid">34822760</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Cochrane Handbook for Systematic Reviews of Interventions. <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook">https://training.cochrane.org/handbook</ext-link>. Accessed 10 Nov 2024</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><etal/></person-group><article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement</article-title><source>Open Med</source><year>2009</year><volume>3</volume><fpage>e123</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">21603045</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3:e123-130<pub-id pub-id-type="pmid">21603045</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Gionchetti</surname><given-names>P</given-names></name><name><surname>Dignass</surname><given-names>A</given-names></name><name><surname>Danese</surname><given-names>S</given-names></name><etal/></person-group><article-title>3rd European evidence-based consensus on the diagnosis and management of Crohn&#x02019;s disease 2016: part 2: surgical management and special situations</article-title><source>J Crohns Colitis</source><year>2017</year><volume>11</volume><fpage>135</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw169</pub-id><pub-id pub-id-type="pmid">27660342</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Gionchetti P, Dignass A, Danese S et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn&#x02019;s disease 2016: part 2: surgical management and special situations. J Crohns Colitis 11:135&#x02013;149. 10.1093/ecco-jcc/jjw169<pub-id pub-id-type="pmid">27660342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Rutgeerts</surname><given-names>P</given-names></name><name><surname>Geboes</surname><given-names>K</given-names></name><name><surname>Vantrappen</surname><given-names>G</given-names></name><etal/></person-group><article-title>Predictability of the postoperative course of Crohn&#x02019;s disease</article-title><source>Gastroenterology</source><year>1990</year><volume>99</volume><fpage>956</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1016/0016-5085(90)90613-6</pub-id><pub-id pub-id-type="pmid">2394349</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Rutgeerts P, Geboes K, Vantrappen G et al (1990) Predictability of the postoperative course of Crohn&#x02019;s disease. Gastroenterology 99:956&#x02013;963. 10.1016/0016-5085(90)90613-6<pub-id pub-id-type="pmid">2394349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Gecse K, Lowenberg M, Bossuyt P et al (2014) Agreement among experts in the endoscopic evaluation of postoperative recurrence in Crohn&#x02019;s disease using the Rutgeerts score. Gastroenterology 146(5):S&#x02013;227. 10.1016/S0016-5085(14)60802-7. (<bold>Supplement 1</bold>)</mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Hutter</surname><given-names>MM</given-names></name><name><surname>Rowell</surname><given-names>KS</given-names></name><name><surname>Devaney</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Identification of surgical complications and deaths: an assessment of the traditional surgical morbidity and mortality conference compared with the American College of Surgeons-National Surgical Quality Improvement Program</article-title><source>J Am Coll Surg</source><year>2006</year><volume>203</volume><fpage>618</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2006.07.010</pub-id><pub-id pub-id-type="pmid">17084322</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Hutter MM, Rowell KS, Devaney LA et al (2006) Identification of surgical complications and deaths: an assessment of the traditional surgical morbidity and mortality conference compared with the American College of Surgeons-National Surgical Quality Improvement Program. J Am Coll Surg 203:618&#x02013;624. 10.1016/j.jamcollsurg.2006.07.010<pub-id pub-id-type="pmid">17084322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Clavien</surname><given-names>PA</given-names></name><name><surname>Barkun</surname><given-names>J</given-names></name><name><surname>de Oliveira</surname><given-names>ML</given-names></name><etal/></person-group><article-title>The Clavien-Dindo classification of surgical complications: five-year experience</article-title><source>Ann Surg</source><year>2009</year><volume>250</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e3181b13ca2</pub-id><pub-id pub-id-type="pmid">19638912</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187&#x02013;196. 10.1097/SLA.0b013e3181b13ca2<pub-id pub-id-type="pmid">19638912</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JA</given-names></name><name><surname>Hern&#x000e1;n</surname><given-names>MA</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><etal/></person-group><article-title>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions</article-title><source>BMJ</source><year>2016</year><volume>355</volume><fpage>i4919</fpage><pub-id pub-id-type="doi">10.1136/bmj.i4919</pub-id><pub-id pub-id-type="pmid">27733354</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Sterne JA, Hern&#x000e1;n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. 10.1136/bmj.i4919<pub-id pub-id-type="pmid">27733354</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JAC</given-names></name><name><surname>Savovi&#x00107;</surname><given-names>J</given-names></name><name><surname>Page</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title><source>BMJ</source><year>2019</year><volume>366</volume><fpage>l4898</fpage><pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id><pub-id pub-id-type="pmid">31462531</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Sterne JAC, Savovi&#x00107; J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. 10.1136/bmj.l4898<pub-id pub-id-type="pmid">31462531</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>BJ</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><etal/></person-group><article-title>AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title><source>BMJ</source><year>2017</year><volume>358</volume><fpage>j4008</fpage><pub-id pub-id-type="doi">10.1136/bmj.j4008</pub-id><pub-id pub-id-type="pmid">28935701</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Shea BJ, Reeves BC, Wells G et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008. 10.1136/bmj.j4008<pub-id pub-id-type="pmid">28935701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Kunz</surname><given-names>R</given-names></name><etal/></person-group><article-title>GRADE guidelines: 7. Rating the quality of evidence&#x02013;inconsistency</article-title><source>J Clin Epidemiol</source><year>2011</year><volume>64</volume><fpage>1294</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2011.03.017</pub-id><pub-id pub-id-type="pmid">21803546</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 7. Rating the quality of evidence&#x02013;inconsistency. J Clin Epidemiol 64:1294&#x02013;1302. 10.1016/j.jclinepi.2011.03.017<pub-id pub-id-type="pmid">21803546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>D</given-names></name><name><surname>Wan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>T</given-names></name></person-group><article-title>Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range</article-title><source>Stat Methods Med Res</source><year>2018</year><volume>27</volume><fpage>1785</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1177/0962280216669183</pub-id><pub-id pub-id-type="pmid">27683581</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27:1785&#x02013;1805. 10.1177/0962280216669183<pub-id pub-id-type="pmid">27683581</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>T</given-names></name></person-group><article-title>Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range</article-title><source>BMC Med Res Methodol</source><year>2014</year><volume>14</volume><fpage>135</fpage><pub-id pub-id-type="doi">10.1186/1471-2288-14-135</pub-id><pub-id pub-id-type="pmid">25524443</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. 10.1186/1471-2288-14-135<pub-id pub-id-type="pmid">25524443</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>CJ</given-names></name><name><surname>Kiernan</surname><given-names>MG</given-names></name><name><surname>Sahebally</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Inclusion of the mesentery in ileocolic resection for Crohn&#x02019;s disease is associated with reduced surgical recurrence</article-title><source>J Crohns Colitis</source><year>2018</year><volume>12</volume><fpage>1139</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1093/ecco-jcc/jjx187</pub-id><pub-id pub-id-type="pmid">29309546</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn&#x02019;s disease is associated with reduced surgical recurrence. J Crohns Colitis 12:1139&#x02013;1150. 10.1093/ecco-jcc/jjx187<pub-id pub-id-type="pmid">29309546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Role of extended mesenteric excision in postoperative recurrence of Crohn&#x02019;s colitis: a single-center study</article-title><source>Clin Transl Gastroenterol</source><year>2021</year><volume>12</volume><fpage>e00407</fpage><pub-id pub-id-type="doi">10.14309/ctg.0000000000000407</pub-id><pub-id pub-id-type="pmid">34597277</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Zhu Y, Qian W, Huang L et al (2021) Role of extended mesenteric excision in postoperative recurrence of Crohn&#x02019;s colitis: a single-center study. Clin Transl Gastroenterol 12:e00407. 10.14309/ctg.0000000000000407<pub-id pub-id-type="pmid">34597277</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Mineccia</surname><given-names>M</given-names></name><name><surname>Maconi</surname><given-names>G</given-names></name><name><surname>Daperno</surname><given-names>M</given-names></name><etal/></person-group><article-title>Has the removing of the mesentery during ileo-colic resection an impact on post-operative complications and recurrence in Crohn&#x02019;s disease? Results from the resection of the mesentery study (Remedy)</article-title><source>J Clin Med</source><year>2022</year><volume>11</volume><fpage>1961</fpage><pub-id pub-id-type="doi">10.3390/jcm11071961</pub-id><pub-id pub-id-type="pmid">35407568</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Mineccia M, Maconi G, Daperno M et al (2022) Has the removing of the mesentery during ileo-colic resection an impact on post-operative complications and recurrence in Crohn&#x02019;s disease? Results from the resection of the mesentery study (Remedy). J Clin Med 11:1961. 10.3390/jcm11071961<pub-id pub-id-type="pmid">35407568</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulkarim</surname><given-names>S</given-names></name><name><surname>Salama</surname><given-names>E</given-names></name><name><surname>Pang</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Extended versus limited mesenteric excision for operative Crohn&#x02019;s disease: 30-Day outcomes from the ACS-NSQIP database</article-title><source>Int J Colorectal Dis</source><year>2023</year><volume>38</volume><fpage>268</fpage><pub-id pub-id-type="doi">10.1007/s00384-023-04561-z</pub-id><pub-id pub-id-type="pmid">37978997</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Abdulkarim S, Salama E, Pang AJ et al (2023) Extended versus limited mesenteric excision for operative Crohn&#x02019;s disease: 30-Day outcomes from the ACS-NSQIP database. Int J Colorectal Dis 38:268. 10.1007/s00384-023-04561-z<pub-id pub-id-type="pmid">37978997</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Does de Willebois</surname><given-names>EML</given-names></name><name><surname>Bellato</surname><given-names>V</given-names></name><name><surname>Duijvestein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn&#x02019;s disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial</article-title><source>Lancet Gastroenterol Hepatol</source><year>2024</year><volume>9</volume><fpage>793</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(24)00097-9</pub-id><pub-id pub-id-type="pmid">39025100</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">van der Does de Willebois EML, Bellato V, Duijvestein M et al (2024) Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn&#x02019;s disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial. Lancet Gastroenterol Hepatol 9:793&#x02013;801. 10.1016/S2468-1253(24)00097-9<pub-id pub-id-type="pmid">39025100</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Ewe</surname><given-names>K</given-names></name><name><surname>Herfarth</surname><given-names>C</given-names></name><name><surname>Malchow</surname><given-names>H</given-names></name><name><surname>Jesdinsky</surname><given-names>HJ</given-names></name></person-group><article-title>Postoperative recurrence of Crohn&#x02019;s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial</article-title><source>Digestion</source><year>1989</year><volume>42</volume><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1159/000199850</pub-id><pub-id pub-id-type="pmid">2572495</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Ewe K, Herfarth C, Malchow H, Jesdinsky HJ (1989) Postoperative recurrence of Crohn&#x02019;s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion 42:224&#x02013;232. 10.1159/000199850<pub-id pub-id-type="pmid">2572495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>JC</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>DP</given-names></name></person-group><article-title>The mesentery: structure, function, and role in disease</article-title><source>Lancet Gastroenterol Hepatol</source><year>2016</year><volume>1</volume><fpage>238</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(16)30026-7</pub-id><pub-id pub-id-type="pmid">28404096</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Coffey JC, O&#x02019;Leary DP (2016) The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 1:238&#x02013;247. 10.1016/S2468-1253(16)30026-7<pub-id pub-id-type="pmid">28404096</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>LL</given-names></name><name><surname>Ayez</surname><given-names>N</given-names></name><name><surname>van Kessel</surname><given-names>CS</given-names></name></person-group><article-title>Crohn&#x02019;s disease: preserve or resect the mesentery?</article-title><source>Br J Surg</source><year>2023</year><volume>110</volume><fpage>1415</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1093/bjs/znad135</pub-id><pub-id pub-id-type="pmid">37178332</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Meijer LL, Ayez N, van Kessel CS (2023) Crohn&#x02019;s disease: preserve or resect the mesentery? Br J Surg 110:1415&#x02013;1418. 10.1093/bjs/znad135<pub-id pub-id-type="pmid">37178332</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mesenteric lymphatic vessel density is associated with disease behavior and postoperative recurrence in Crohn&#x02019;s disease</article-title><source>J Gastrointest Surg</source><year>2018</year><volume>22</volume><fpage>2125</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1007/s11605-018-3884-9</pub-id><pub-id pub-id-type="pmid">30043133</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Li Y, Ge Y, Gong J et al (2018) Mesenteric lymphatic vessel density is associated with disease behavior and postoperative recurrence in Crohn&#x02019;s disease. J Gastrointest Surg 22:2125&#x02013;2132. 10.1007/s11605-018-3884-9<pub-id pub-id-type="pmid">30043133</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>DQ</given-names></name><name><surname>Moore</surname><given-names>GT</given-names></name><name><surname>Strauss</surname><given-names>BJG</given-names></name><etal/></person-group><article-title>Visceral adiposity predicts post-operative Crohn&#x02019;s disease recurrence</article-title><source>Aliment Pharmacol Ther</source><year>2017</year><volume>45</volume><fpage>1255</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1111/apt.14018</pub-id><pub-id pub-id-type="pmid">28244124</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Holt DQ, Moore GT, Strauss BJG et al (2017) Visceral adiposity predicts post-operative Crohn&#x02019;s disease recurrence. Aliment Pharmacol Ther 45:1255&#x02013;1264. 10.1111/apt.14018<pub-id pub-id-type="pmid">28244124</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>M</given-names></name><name><surname>Coffey</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Mesenteric-based surgery for Crohn&#x02019;s disease: evidence and perspectives</article-title><source>Surgery</source><year>2024</year><volume>176</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2024.02.025</pub-id><pub-id pub-id-type="pmid">38594102</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Duan M, Coffey JC, Li Y (2024) Mesenteric-based surgery for Crohn&#x02019;s disease: evidence and perspectives. Surgery 176:51&#x02013;59. 10.1016/j.surg.2024.02.025<pub-id pub-id-type="pmid">38594102</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Yzet</surname><given-names>C</given-names></name><name><surname>Riault</surname><given-names>C</given-names></name><name><surname>Brazier</surname><given-names>F</given-names></name><etal/></person-group><article-title>Positive margins and plexitis increase the risk of recurrence after ileocecal resection: a systematic review and meta-analysis</article-title><source>Dig Liver Dis</source><year>2023</year><volume>55</volume><fpage>1611</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.1016/j.dld.2022.12.021</pub-id><pub-id pub-id-type="pmid">36658042</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yzet C, Riault C, Brazier F et al (2023) Positive margins and plexitis increase the risk of recurrence after ileocecal resection: a systematic review and meta-analysis. Dig Liver Dis 55:1611&#x02013;1620. 10.1016/j.dld.2022.12.021<pub-id pub-id-type="pmid">36658042</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SR</given-names></name><name><surname>Ow</surname><given-names>ZGW</given-names></name><name><surname>Chin</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Quantifying the rate of recurrence of postoperative Crohn&#x02019;s disease with biological therapy</article-title><source>A meta-analysis J Dig Dis</source><year>2021</year><volume>22</volume><fpage>399</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1111/1751-2980.13025</pub-id><pub-id pub-id-type="pmid">34048153</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Jain SR, Ow ZGW, Chin YH et al (2021) Quantifying the rate of recurrence of postoperative Crohn&#x02019;s disease with biological therapy. A meta-analysis J Dig Dis 22:399&#x02013;407. 10.1111/1751-2980.13025<pub-id pub-id-type="pmid">34048153</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Buskens</surname><given-names>CJ</given-names></name><name><surname>Bemelman</surname><given-names>WA</given-names></name></person-group><article-title>Inclusion of the mesentery in ileocolic resection for Crohn&#x02019;s disease is associated with reduced surgical recurrence : editorial by Coffey et al</article-title><source>J Crohns Colitis</source><year>2018</year><volume>12</volume><fpage>1137</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1093/ecco-jcc/jjy115</pub-id><pub-id pub-id-type="pmid">30137343</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Buskens CJ, Bemelman WA (2018) Inclusion of the mesentery in ileocolic resection for Crohn&#x02019;s disease is associated with reduced surgical recurrence&#x0202f;: editorial by Coffey et al. J Crohns Colitis 12:1137&#x02013;1138. 10.1093/ecco-jcc/jjy115<pub-id pub-id-type="pmid">30137343</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Nardone</surname><given-names>OM</given-names></name><name><surname>Calabrese</surname><given-names>G</given-names></name><name><surname>Barberio</surname><given-names>B</given-names></name><etal/></person-group><article-title>Rates of endoscopic recurrence in postoperative Crohn&#x02019;s disease based on anastomotic techniques: a systematic review and meta-analysis</article-title><source>Inflamm Bowel Dis</source><year>2024</year><volume>30</volume><fpage>1877</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1093/ibd/izad252</pub-id><pub-id pub-id-type="pmid">37931290</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Nardone OM, Calabrese G, Barberio B et al (2024) Rates of endoscopic recurrence in postoperative Crohn&#x02019;s disease based on anastomotic techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 30:1877&#x02013;1887. 10.1093/ibd/izad252<pub-id pub-id-type="pmid">37931290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Lemke</surname><given-names>M</given-names></name><name><surname>Ghuman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of Kono-S anastomosis on reducing postoperative recurrence rates in Crohn&#x02019;s disease: a systematic review and meta-analysis</article-title><source>Tech Coloproctol</source><year>2024</year><volume>28</volume><fpage>127</fpage><pub-id pub-id-type="doi">10.1007/s10151-024-02991-7</pub-id><pub-id pub-id-type="pmid">39289220</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Lin W, Lemke M, Ghuman A et al (2024) Effect of Kono-S anastomosis on reducing postoperative recurrence rates in Crohn&#x02019;s disease: a systematic review and meta-analysis. Tech Coloproctol 28:127. 10.1007/s10151-024-02991-7<pub-id pub-id-type="pmid">39289220</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Holubar</surname><given-names>SD</given-names></name><name><surname>Gunter</surname><given-names>RL</given-names></name><name><surname>Click</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Mesenteric excision and exclusion for ileocolic Crohn&#x02019;s disease: feasibility and safety of an innovative, combined surgical approach with extended mesenteric excision and Kono-S anastomosis</article-title><source>Dis Colon Rectum</source><year>2022</year><volume>65</volume><fpage>e5</fpage><lpage>e13</lpage><pub-id pub-id-type="doi">10.1097/DCR.0000000000002287</pub-id><pub-id pub-id-type="pmid">34882636</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Holubar SD, Gunter RL, Click BH et al (2022) Mesenteric excision and exclusion for ileocolic Crohn&#x02019;s disease: feasibility and safety of an innovative, combined surgical approach with extended mesenteric excision and Kono-S anastomosis. Dis Colon Rectum 65:e5&#x02013;e13. 10.1097/DCR.0000000000002287<pub-id pub-id-type="pmid">34882636</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Pouillon</surname><given-names>L</given-names></name><name><surname>Remen</surname><given-names>T</given-names></name><name><surname>Amicone</surname><given-names>C</given-names></name><etal/></person-group><article-title>Risk of late postoperative recurrence of Crohn&#x02019;s disease in patients in endoscopic remission after ileocecal resection, over 10 years at multiple centers</article-title><source>Clin Gastroenterol Hepatol</source><year>2021</year><volume>19</volume><fpage>1218</fpage><lpage>1225.e4</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2020.05.027</pub-id><pub-id pub-id-type="pmid">32445951</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Pouillon L, Remen T, Amicone C et al (2021) Risk of late postoperative recurrence of Crohn&#x02019;s disease in patients in endoscopic remission after ileocecal resection, over 10 years at multiple centers. Clin Gastroenterol Hepatol 19:1218-1225.e4. 10.1016/j.cgh.2020.05.027<pub-id pub-id-type="pmid">32445951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Does de Willebois</surname><given-names>EML</given-names></name><collab>SPICY study group</collab></person-group><article-title>Mesenteric SParIng versus extensive mesentereCtomY in primary ileocolic resection for ileocaecal Crohn&#x02019;s disease (SPICY): study protocol for randomized controlled trial</article-title><source>BJS Open</source><year>2022</year><volume>6</volume><fpage>zrab136</fpage><pub-id pub-id-type="doi">10.1093/bjsopen/zrab136</pub-id><pub-id pub-id-type="pmid">35171266</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">van der Does de Willebois EML, SPICY study group (2022) Mesenteric SParIng versus extensive mesentereCtomY in primary ileocolic resection for ileocaecal Crohn&#x02019;s disease (SPICY): study protocol for randomized controlled trial. BJS Open 6:zrab136. 10.1093/bjsopen/zrab136<pub-id pub-id-type="pmid">35171266</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Gecse</surname><given-names>KB</given-names></name><name><surname>Duijvestein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reliability of endoscopic evaluation of postoperative recurrent Crohn&#x02019;s disease</article-title><source>Clin Gastroenterol Hepatol</source><year>2020</year><volume>18</volume><fpage>2139</fpage><lpage>2141.e2</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2019.08.046</pub-id><pub-id pub-id-type="pmid">31473359</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ma C, Gecse KB, Duijvestein M et al (2020) Reliability of endoscopic evaluation of postoperative recurrent Crohn&#x02019;s disease. Clin Gastroenterol Hepatol 18:2139-2141.e2. 10.1016/j.cgh.2019.08.046<pub-id pub-id-type="pmid">31473359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Does de Willebois</surname><given-names>EML</given-names></name><name><surname>Bellato</surname><given-names>V</given-names></name><name><surname>Duijvestein</surname><given-names>M</given-names></name><etal/></person-group><article-title>How reliable is endoscopic scoring of postoperative recurrence in Crohn disease?: a systematic review and meta-analysis</article-title><source>Ann Surg Open</source><year>2024</year><volume>5</volume><fpage>e397</fpage><pub-id pub-id-type="doi">10.1097/AS9.0000000000000397</pub-id><pub-id pub-id-type="pmid">38883962</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">van der Does de Willebois EML, Bellato V, Duijvestein M et al (2024) How reliable is endoscopic scoring of postoperative recurrence in Crohn disease?: a systematic review and meta-analysis. Ann Surg Open 5:e397. 10.1097/AS9.0000000000000397<pub-id pub-id-type="pmid">38883962</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><collab>ASGE Ibd Endoscopy Consensus Panel</collab><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Abreu</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel</article-title><source>Gastrointest Endosc</source><year>2024</year><volume>S0016&#x02013;5107</volume><issue>24</issue><fpage>03472</fpage><lpage>3482</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2024.08.034</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">ASGE Ibd Endoscopy Consensus Panel, Shen B, Abreu MT et al (2024) Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel. Gastrointest Endosc S0016&#x02013;5107(24):03472&#x02013;03482. 10.1016/j.gie.2024.08.034</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Adamina</surname><given-names>M</given-names></name><name><surname>Minozzi</surname><given-names>S</given-names></name><name><surname>Warusavitarne</surname><given-names>J</given-names></name><etal/></person-group><article-title>ECCO guidelines on therapeutics in Crohn&#x02019;s disease: surgical treatment</article-title><source>J Crohns Colitis</source><year>2024</year><volume>18</volume><fpage>1556</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1093/ecco-jcc/jjae089</pub-id><pub-id pub-id-type="pmid">38878002</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Adamina M, Minozzi S, Warusavitarne J et al (2024) ECCO guidelines on therapeutics in Crohn&#x02019;s disease: surgical treatment. J Crohns Colitis 18:1556&#x02013;1582. 10.1093/ecco-jcc/jjae089<pub-id pub-id-type="pmid">38878002</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Luglio</surname><given-names>G</given-names></name><name><surname>Rispo</surname><given-names>A</given-names></name><name><surname>Imperatore</surname><given-names>N</given-names></name><etal/></person-group><article-title>Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn&#x02019;s disease: the SuPREMe-CD study - a randomized clinical trial</article-title><source>Ann Surg</source><year>2020</year><volume>272</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000003821</pub-id><pub-id pub-id-type="pmid">32675483</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Luglio G, Rispo A, Imperatore N et al (2020) Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn&#x02019;s disease: the SuPREMe-CD study - a randomized clinical trial. Ann Surg 272:210&#x02013;217. 10.1097/SLA.0000000000003821<pub-id pub-id-type="pmid">32675483</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Kelm</surname><given-names>M</given-names></name><name><surname>Benatzky</surname><given-names>C</given-names></name><name><surname>Buck</surname><given-names>V</given-names></name><etal/></person-group><article-title>Positive resection margins in Crohn&#x02019;s disease are a relevant risk factor for postoperative disease recurrence</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><fpage>10823</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-61697-w</pub-id><pub-id pub-id-type="pmid">38734721</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Kelm M, Benatzky C, Buck V et al (2024) Positive resection margins in Crohn&#x02019;s disease are a relevant risk factor for postoperative disease recurrence. Sci Rep 14:10823. 10.1038/s41598-024-61697-w<pub-id pub-id-type="pmid">38734721</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Kelm</surname><given-names>M</given-names></name><name><surname>Flemming</surname><given-names>S</given-names></name></person-group><article-title>Mesenteric sparing or extended resection in primary ileocolic resection for Crohn&#x02019;s disease</article-title><source>Lancet Gastroenterol Hepatol</source><year>2025</year><volume>10</volume><fpage>15</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(24)00343-1</pub-id><pub-id pub-id-type="pmid">39674212</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Kelm M, Flemming S (2025) Mesenteric sparing or extended resection in primary ileocolic resection for Crohn&#x02019;s disease. Lancet Gastroenterol Hepatol 10:15&#x02013;16. 10.1016/S2468-1253(24)00343-1<pub-id pub-id-type="pmid">39674212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">NCT03172143 (2018) Mesenteric sparing for the prevention of recurrent Crohn&#x02019;s disease. <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/show/NCT03172143">https://clinicaltrials.gov/show/NCT03172143</ext-link>. 10.1002/central/CN-01594650</mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">NCT04578392 (2020) MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn&#x02019;s DiseaSe (SPARES). <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/show/NCT04578392">https://clinicaltrials.gov/show/NCT04578392</ext-link>. 10.1002/central/CN-02181819</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Mohan</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mesenteric excision surgery or conservative limited resection in Crohn&#x02019;s disease: study protocol for an international, multicenter, randomized controlled trial</article-title><source>Trials</source><year>2020</year><volume>21</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.1186/s13063-020-4105-x</pub-id><pub-id pub-id-type="pmid">32085793</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Li Y, Mohan H, Lan N et al (2020) Mesenteric excision surgery or conservative limited resection in Crohn&#x02019;s disease: study protocol for an international, multicenter, randomized controlled trial. Trials 21:210. 10.1186/s13063-020-4105-x<pub-id pub-id-type="pmid">32085793</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>